[nle27]ghrh-(1-29)-nh2

[nle27]ghrh-(1-29)-nh2 has been studied in 1 paper since 1997: 1 trial in people. The newest paper, May 1, 1997: “Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women”.

Intervention

1 paper studies it6 findingsUpdated

More peptides

See all 1 papers on [nle27]ghrh-(1-29)-nh2

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Compared with placebo, GHRH analog induced a significant increase in 12-h integrated nocturnal GH levels in women (P < 0.01) and men (P < 0.05).”
Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and womenThe Journal of clinical endocrinology and metabolism1997doi:10.1210/jcem.82.5.3943

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: National Center for Advancing Translational Sciences and 3 more
  • Human trial1

Studies in people

1 study gave [nle27]ghrh-(1-29)-nh2 to people and measured what changed.

What changedDesignPeopleSource

up: Increases nocturnal GH

up: Increases skin thickness

up: Increases lean body mass

Randomized trial16 weeks9 peopleBoth55–71 yearsMidlife adults; Older adultsThe Journal of clinical endocrinology and metabolism, May 1, 1997

What did studies of [nle27]ghrh-(1-29)-nh2 find?

6

Studies of [nle27]ghrh-(1-29)-nh2 measured 6 outcomes, among them hyperlipidemia, general well-being and insulin sensitivity.

Hyperlipidemia

upin humans1

1 study
  1. [nle27]ghrh-(1-29)-nh2 induces hyperlipidemia in humans.

    “The only adverse side-effect was transient hyperlipidemia, which resolved by the end of the study.”

    Human trial10 microg/kg nightlyresolved by the end of the study

    Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

    The Journal of clinical endocrinology and metabolism

More on Hyperlipidemia

General well-being

upin humans1

1 study
  1. [nle27]ghrh-(1-29)-nh2 improves general well-being in humans.

    “a significant improvement in general well-being (P < 0.05) and libido (P < 0.01) in men, but not in women”

    Human trial10 microg/kg nightly16 weeksmalesn = 9

    Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

    The Journal of clinical endocrinology and metabolism

Insulin sensitivity

upin humans1

1 study
  1. [nle27]ghrh-(1-29)-nh2 increases insulin sensitivity in humans.

    “a significant increase in insulin sensitivity occurred in men (P < 0.05), but not in women.”

    Human trial10 microg/kg nightly16 weeksmalesn = 9

    Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

    The Journal of clinical endocrinology and metabolism

Lean body mass

upin humans1

1 study
  1. [nle27]ghrh-(1-29)-nh2 increases lean body mass in humans.

    “increased lean body mass in men only (P < 0.05)”

    Human trial10 microg/kg nightly16 weeksmalesn = 9

    Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

    The Journal of clinical endocrinology and metabolism

Skin thickness

upin humans1

1 study
  1. [nle27]ghrh-(1-29)-nh2 increases skin thickness in humans.

    “GHRH analog treatment resulted in a significant increase in skin thickness (P < 0.05) in both genders”

    Human trialskin10 microg/kg nightly16 weeks

    Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

    The Journal of clinical endocrinology and metabolism

Nocturnal GH

upin humans1

1 study
  1. [nle27]ghrh-(1-29)-nh2 increases nocturnal GH in humans (compared with placebo).

    “Compared with placebo, GHRH analog induced a significant increase in 12-h integrated nocturnal GH levels in women (P < 0.01) and men (P < 0.05).”

    Human trialcompared with placebo10 microg/kg nightly16 weeks

    Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

    The Journal of clinical endocrinology and metabolism

More on Nocturnal GH

Latest